insights_auto
Why is EDIT down 3,01%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,77 US$
arrow_downward
-3,01%(-0,055) 1D
1,81 US$
arrow_upward
+2,26% (+0,040)bedtimeAfter hours
Closed: 18 ნოე, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,86 US$
High
1,94 US$
Low
1,76 US$
Mkt. cap
272,43 მლნ.
Avg. vol.
2,39 მლნ.
Volume
1,99 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
Open
1,86 US$
High
1,94 US$
Low
1,76 US$
Mkt. cap
272,43 მლნ.
Avg. vol.
2,39 მლნ.
Volume
1,99 მლნ.
52-wk high
3,94 US$
52-wk low
1,66 US$
EPS
-0,62 US$
Beta
2,09
Shares outstanding
154,34 მლნ.
No. of employees
87
News stories
From web sources and news partners
Foreign Policy Journal
·
5 წუთის წინ
S&P 500 (SPY) and Dow Jones Industrial Average (DJIA) Hit Multi-Month Lows As Software Rout And Bitcoin Slide Hammer Broad Market
FXStreet
·
3 საათის წინ
Dow Jones Industrial Average drops as UnitedHealth and Nvidia fall
FOREX.com
·
4 საათის წინ
S&P 500 Grasps At Support as Surging Hike Odds, Treasury Yields Threaten Larger Turn
Traders Union
·
3 საათის წინ
Peter Tuchman: S&P 500 loses $2.5 trillion in market cap over five days
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc